Equinatoxin II is a pore forming protein of the actinoporin family. After membrane binding, it inserts its N-terminal α-helix and forms a protein/lipid pore. Equinatoxin II activity depends on the presence of sphingomyelin in the target membrane; however the role of this specificity is unknown. On the other hand, sphingomyelin is considered to be an essential ingredient of lipid rafts and promotes liquid-ordered/liquid-disordered phase separation in model membranes that mimic raft composition. Here we have used giant unilamellar vesicles to simultaneously investigate the effect of sphingomyelin and phase separation on the membrane binding and permeabilizing activity of Equinatoxin II. Our results show that Equinatoxin II binds preferentially to the liquid ordered phase over the liquid disordered one, and that it tends to concentrate at domain interfaces. In addition, sphingomyelin strongly enhanced membrane binding of the toxin, but was not sufficient for membrane permeabilization. Under the same experimental conditions, Equinatoxin II formed pores in giant unilamellar vesicles containing sphingomyelin only when liquid ordered and disordered phases coexisted. Our observations demonstrate the importance of phase boundaries for Equinatoxin II activity and suggest a double role of sphingomyelin as a specific receptor for the toxin and as a promoter of the membrane organization necessary for Equinatoxin II action.
Introduction
Pore forming toxins (PFTs) are a group of toxic molecules that exert their action by increasing the permeability of their target membranes. As a consequence, ion gradients are disrupted, which provokes osmotic swelling and cell death (1) . An interesting trait common to all PFTs is that they present two stable structures: they are synthesized as water soluble monomers and insert into cell membranes to exert their action (2) . Then, PFTs follow a variety of mechanisms to induce the formation of membrane pores (3) . Some of them, like bacterial cytolysins and the staphylococcal α-toxin, form β-barrel channels (4, 5) . Others induce pores by insertion of α-helices: they organize into pure protein α-helix bundles, like the antimicrobial peptide alamethicin, or form mixed lipid/protein structures known as toroidal pores (as in the case of actinoporins, colicins, and magainin or melittin) (6) . Toroidal pores are unstable and have not yet been visualized. As a consequence, few structural information is available (7) . Equinatoxin II (EqtII) belongs to the family of actinoporins, eukaryotic PFTs exclusively found in sea anemones, whose activity depends on the presence of sphingomyelin (SM) in the target membrane (8) . It efficiently lyses several cell types and shows permeabilizing activity in model membranes. The structure of the water soluble form of EqtII has been determined (9, 10) . It contains 179 amino acids (19.8 kDa) that arrange into a hydrophobic β-sandwich core surrounded by two α-helices on both sides. The first 30 N-terminal residues contain an α-helix that undergoes conformational changes during membrane insertion and pore formation (11) . The flexibility of this α-helix is necessary for EqtII activity (12) . Some aspects of the mechanism of action of EqtII at the molecular level have been unveiled during the last years. It includes an initial step of membrane binding, in which a cluster of exposed aromatic residues are involved (12) (13) (14) . Then, the N-terminal helix dissociates from the β-sandwich core, inserts into the lipid-water interface and adopts an orientation parallel to the membrane plane (3, 11) . Subsequently, EqtII monomers oligomerize and the N-terminal helix reorients and crosses the bilayer to form the pore (11, 15) . Several studies suggest that the EqtII pore is formed by 3-4 monomers that arrange into a toroidal structure lined by Nterminal α-helices and lipids (16, 17) .
The role of SM in target membrane specificity is unknown. It is essential for irreversible binding of EqtII and pore formation, but it is not sufficient to provoke the dissociation of the N-terminal helix from the β-sandwich in the presence of phosphatidylcholine micelles and bicelles (18) . On the other hand, SM is a substantial ingredient of lipid rafts, which are suposedly associated to the coexistence of liquid disordered (L d ) and SM-enriched liquid ordered (L o ) lipid phases (19) . In this context, phase coexistence in SM-containing membranes has been suggested to favor membrane insertion of EqtII into the lipid packing defects at the interface (20) . During the last years, giant unilamellar vesicles (GUVs) have been proven to be valuable models for the study of processes at lipid membranes. With diameters varying from a few to a hundred microns, GUVs have sizes comparable to eukaryotic cells and are well distinguished by optical microscopy. In addition to studies of membrane elasticity and shape change (21, 22) , GUVs have been especially useful for the investigation of phase separating membranes and lipid domains (23) (24) (25) . In GUVs with raft-like composition, macroscopic domains corresponding to L o , enriched in SM, and L d phases can be clearly distinguished thanks to heterogeneous partitioning of fluorescent markers (25, 26) . GUVs have also been used to study membrane permeabilization (27, 28) and the effect of EqtII pores on the transport of sucrose and glucose molecules (29) . The main advantage of using GUVs versus the traditional methods based in small and large unilamellar vesicles (LUVs) is that optical measurements can be performed at the single vesicle and even single molecule level while tracking membrane integrity. This provides novel information about the mechanism of pore formation. In this work, we have used GUVs to simultaneously investigate the role of SM and lipid phase coexistence in the membrane binding and permeabilizing activity of EqtII. Our results show that EqtII binds preferentially to the SM-enriched L o phase than to the L d phase. Interestingly, it concentrates at the domain interface. Although, the presence of SM strongly promoted membrane binding, SM in a single-phase membrane was not sufficient for membrane permeabilization. At the same protein concentration, EqtII was able to permeabilize SM containing GUVs only when L d and L o phases coexisted. Our observations demonstrate the importance of the phase interface for EqtII activity and suggest the pivotal role of SM in acting as a specific receptor for EqtII while promoting the membrane organization necessary for EqtII action.
Materials and Methods

Chemicals
1,2-Dioleoyl-sn-glycero-3-phosphocholine (dioleoyl-phosphatidylcholine; DOPC), 1,2-Dipalmitoyl-sn-Glycero-3-Phosphocholine (DPPC), N-stearoyl-Derythrosphingosylphosphorylcholine (stearoyl sphingomyelin, SM) and cholesterol were purchased from Avanti Polar Lipids (Alabaster, AL). 1,1'-Dioctadecyl-3,3,3',3'-tetramethylindodicarbocyanine perchlorate (DiD) and 1,1'-Dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate (DiI) were from Invitrogen (Carlsbad, CA).
Protein purification and labeling
Two single cysteine mutants of EqtII, EqtII-V22C and EqtII-L26C were produced as in (11) . The two purified mutants EquII-V22C and EquIIL-26C were labeled with Alexa Fluor® 488 C 5 maleimide (Invitrogen) according to manufacturer's instructions. The separation of the labeled protein from the free dye was achieved by a 10DG gel filtration column from BioRad (Hercules, CA) and the labeling was checked by spectroscopy measurements done with a Specord S 100 from Analytik Jena (Jena, Germany).
Preparation of Giant Unilamellar Vesicles (GUVs)
GUVs were prepared by electroformation (30) . With this approach, truly unilamellar vesicles are produced with sizes varying from 10 μm to 100 μm. The electroformation chamber consists of two glass slides coated with optically transparent and electrically conductive indium tin oxide (ITO) that are held apart by a Teflon or rubber spacer. Three µl of the corresponding lipid mixture (10mg/ml) together with 0.1% DiD or DiI (31) in chloroform/methanol 2:1 were deposited on the preheated ITO-glasses and the solvent evaporated at 65 ºC. After adding a 300 mM sucrose solution into the chamber, a voltage of 1.4 V at 10 Hz was applied overnight. The electroformed vesicles were then carefully pipetted out of the electroformation chamber and sedimented in 800 µl PBS (phosphatebuffer saline: 137mM NaC, 10mM phosphate, 2.7mM KCl, pH 7.4). After a few minutes either 150 µl were pipetted out from the bottom of the tube and distributed into the four compartments of the observation chamber (Invitrogen) or 200µl from several GUVcontaining tubes were combined, gently mixed and then an 8-well observation chamber was filled with 100 µl per well. All preparation steps were done at 65 °C to avoid lipid demixing. During cool-down to room temperature in the observation chambers, phase separation into L o and L d phases occurs, DiD and DiI almost exclusively distributing into the L d phase.
Confocal microscopy
Images were obtained at room temperature by confocal fluorescence microscopy, performed on a commercial ConfoCor3 from Zeiss (Jena, Germany) with a laser scanning microscopy (LSM) module. The excitation light of an Ar ion laser at 488 nm and of a HeNe laser at 633 nm was reflected by a dichroic mirror (HFT 488/633) and focused through a Zeiss CApochromat 40x, NA=1.2 water immersion objective onto the sample. The fluorescence emission was recollected by the same objective and split by another dichroic mirror (NFT 545) into two channels. Detection of the fluorescence emission, after passing a 505-530 nm band pass filter in the first channel and a 650 nm long pass filter in the second channel, was obtained with two avalanche photo diodes (APDs).
Measurements of membrane binding and permeabilization
Protein binding distributions were calculated by sampling over several vesicle preparations. We quantified the fluorescence intensities of EqtII-Al488 in the L o and the L d phases within a single vesicle and calculated the intensity ratio I F Lo /I F Ld half an hour after the addition of about 10µg/ml (final concentration) of one of the labeled EqtII mutants. Pore activity measurements were done by adding a PBS solution containing Alexa Fluor® 488 (molecular weight 720 Da) as a marker as well as the unlabeled EqtII to the vesicles and gently mixing the sample to achieve a largely homogeneous distribution of vesicles, marker and protein. After 45 minutes the number of GUVs into which the marker had penetrated was counted versus the total number of vesicles in several regions of the sample. Up to 600 vesicles were evaluated per data point. The degree of filling was determined by taking a sample image every 30 seconds and comparing the intensity of the fluorescence marker within a vesicle with the intensity just outside the GUV.
Results
EqtII prefers the L o over the L d phase and concentrates at the domain interface
EqtII binding and insertion into lipid membranes is affected by the presence of SM (17) , which is related cellular lipid rafts (32) . Model membranes that contain SM, DOPC and cholesterol in a raft-like composition show coexistence of L d and L o phases (26, 31, 33, 34) . The L o phase is enriched in SM and is characterized by conformational order in the lipid acyl chains, while their lateral and rotational lipid mobility is more similar to the L d phase than to the gel phase (32) . In order to investigate the effect of membrane phase and composition on the binding affinity of EqtII, we performed binding experiments in GUVs with different lipid mixtures. As explained in Materials and Methods, two EqtII mutants were labeled to homogeneity and used for experiments. The mutations used were from the N-terminal region, which is not close to the region of the molecule that interacts with the lipid membrane (12, 13, 18) . In our experiments, the two mutants showed exactly the same behavior, both in binding and permeabilization. When the mutant is not specified, the general name EqtII-Al488 is used to denote results obtained for both labeled mutants. We added EqtII-Al488 to GUVs containing SM or not, with only L d or L o phase, or L d -L o phase coexistence. The membranes were labeled with DiD or DiI, which partition preferentially to the L d phase (25) . After 30 min incubation, we checked for membrane binding by confocal microscopy. As observed in Figure 1 , EqtII-Al488 binds preferentially to vesicles containing SM. In Figure 1 , panels E to H, a control without SM (lipid compositon DOPC/cholesterol (1:1)) shows no membrane binding of the toxin under these conditions. When EqtII-V22C-Al488 was added to a mixture of SM-containing GUVs with only L o (SM/cholesterol, 1:1) or L d (SM/DOPC, 1:1) phase (25) , the toxin bound preferentially to the vesicles in the L o phase (see Figure 1 , A, B, C and D). Interestingly, intense dots of EqtII-L26C-Al488 localize at some of the phase boundaries, indicating a tendency of the protein to concentrate at the interface. Assuming that the fluorescence intensity in GUVs is proportional to EqtII-Al488 concentration, we quantified the phase binding preference of EqtII-Al488 by calculating the partitioning of the protein between both L o and L d phases in a large number of different vesicles. The results obtained are represented in Figure 2 and include data from both mutants. The spread of the data is indicative of the heterogeneity of the system. EqtII-Al488 bound more extensively to the L o phase in the majority of the vesicles (69%), ranging from 1.5-fold to 10-fold preference for this phase. A minor number of vesicles exhibited homogeneous distribution or higher concentration in the L d phase.
EqtII pore forming activity depends on the presence of phase separation
To determine whether the differences observed in binding affinity have an effect on the pore forming activity of EqtII, we carried out experiments of membrane permeabilization in GUVs. GUVs of the desired lipid compositions were prepared and Alexa-488 together with unlabeled EqtII was added to the external solution. Vesicle permeabilization caused an increase in fluorescence intensity inside the GUVs, indicative of filling with Alexa-488. Such a system allows simultaneous verification of vesicle integrity and L d -L o phase coexistence while measuring pore activity. Figure 3 shows the vesicles immediately after addition of Alexa-488 and EqtII to the external medium (panels A to D) and after 45 minutes of incubation at room temperature (panels E to H). In all cases vesicles retained their integrity upon toxin treatment. The GUVs in panels A and E were made of DOPC/cholesterol (1:1) and were not permeabilized after incubation with EqtII. Under similar conditions, EqtII showed pore forming activity in vesicles composed of DOPC:SM:cholesterol (1:1:1), which exhibit L d -L o phase separation (Figure 3 , panels C and G). However, GUVs containing SM but no phase coexistence (SM:cholesterol, 1:1) were not permeabilized by EqtII (Figure 3, panels B and F) , in spite of toxin binding to the membrane (as shown in Figure 1 , panels E to H). As a control, BSA (Bovine Serum Albumin) was added to GUVs made of DOPC:SM:cholesterol (1:1:1) and only rare vesicle permeabilization was observed (panels D and H). These observations indicate that phase separation has a strong effect in promoting EqtII pore forming activity. To check this possibility, we measured EqtII permeabilizing activity in GUVs composed of DOPC:DPPC:cholesterol (1:1:1), which do not contain SM but also exhibit a phase coexistence. As summarized in Table 1 , under the same conditions, EqtII was able to permeabilize 67% of vesicles, in comparison with 98% activity in DOPC:SM:cholesterol (1:1:1). Interestingly, the addition of SM to only 5% (DOPC:DPPC:cholesterol:SM, 1:1:1:0.16) recuperated the activity of EqtII to 96%. Our results indicate that the coexistence of L d and L o phases is enough to enhance the pore forming activity of EqtII, and that the presence of SM has a synergistic effect by increasing EqtII binding to the membrane.
Permeabilization of GUVs is a stochastic and fast event
Bulk experiments of vesicle permeabilization show cooperative behavior in the concentration dependent activity of many pore forming toxins, including EqtII (17, (35) (36) (37) (38) . In contrast to traditional assays of content release from LUVs (which inform about the average permeabilization from all the LUVs in the suspension), permeabilization experiments in GUVs provide information about events at the single vesicle level (they analyze the fraction of the permeabilized vesicles among all the examined ones). To check if the information obtained from GUVs is comparable to content release experiments in LUVs, we measured the pore activity of EqtII at several protein concentrations. Figure 4 shows the percentage of vesicles permeabilized as a function of the toxin concentration. The activity curve obtained is similar to the results obtained in bulk experiments (17) . Under our experimental conditions, 50% of vesicles were permeabilized at approximately 4.3 μg/mL of EqtII. In addition to average activity, experiments of GUV permeabilization allow us to investigate the filling kinetics of single vesicles. Figure 5 .A shows the grade of vesicle filling as a function of time for several individual vesicles. In general, membrane permeabilization started at around 20 min after mixing the GUVs with EqtII. After this lag time, the increase of fluorescence intensity inside the vesicles started stochastically and complete filling was rapidly achieved, within times varying from around 1 to 5 min. From these data, we can calculate the volume flux J V through the membrane. Assuming a constant fluorophore concentration c ext , set 1 for simplicity, the fluorophore concentration c(t) inside a GUV will change during the time interval dt like:
Where dN ext i and dN i ext are the fluorophores that cross the membrane from the outside to the inside and vice versa respectively and V i as the vesicle volume, also assumed to be constant. With c=N/V this leads to:
with A as the vesicle surface. Since the GUVs can be regarded as spheres, A = 4πR² and V = 4π/3 R³ the above expression can be written as the differential equation:
The starting condition c(0) =c 0 =0 yields the solution: Table 2 shows the volume flux J V in the individual vesicles, calculated from the slopes in Figure 5 .B according to equation 5. The spread values obtained show the heterogeneity of the filling process, with gives an average filling flux of 8±5 μm/min.
Discussion
Permeabilization of single vesicles
We used a similar approach to Yamazaki and coworkers for membrane permeabilization studies in single GUVs (28, 39) . Our results show that membrane permeabilization by EqtII in single vesicles was comparable to bulk experiments when averaged. But in addition, they allowed us to confirm vesicle integrity during permeabilization and to simultaneously measure the filling kinetics at the single vesicle level. We observed that after addition of the toxin, a lag time of around 20 min was necessary for pore formation. A similar behavior was obtained in bulk experiments of vesicle permeabilization and hemolysis (17) . Since binding to lipid membranes occurs in seconds (12) , processes like oligomerization, conformational changes and insertion of the N-terminus α-helix probably contribute to the lag time. This is also in agreement with the two-state model of pore formation by Huang and colleages (40) . According to this model, toxin binding to the outer leaflet would introduce additional area, so that a stress in the membrane, or membrane tension, would be created. After enough toxin molecules have bound, the membrane tension generated would destabilize the bilayer and provoke pore opening. Though no membrane thinning effect has been measured for EqtII to date, insertion of the N-terminal α-helix of EqtII, which is related to pore formation (3, 15) , has been shown to increase the lateral pressure in monolayers (12) . The variations in the lag time for pore formation measured in the individual vesicles are probably related to the heterogeneities in the system and the stochastic nature of pore opening (28) . Once pore opening took place, vesicle filling was fast and complete within few minutes. This is in the same time range observed for other molecules, like magainin or epigallocatechin gallate (28, 39) . We derived an equation to calculate the rate of vesicle filling. The differences observed in the estimated filling fluxes may arise from a different number of pores per vesicle, from pores with different size, and/or from a different Laplace pressure in the individual vesicles (41) .
Role of SM in EqtII activity
The presence of SM enhances binding of EqtII to the membrane (20) . Although the molecular basis for this lipid specificity is unknown, SM is necessary for the irreversible binding of the toxin to the membrane, which is followed by insertion and pore formation (42) . However, as shown by nuclear magnetic resonance (NMR) studies, SM is not sufficient to trigger the conformational change that inserts the N-terminal α-helix responsible of pore opening, at least in micelle and bicelle model membrane systems (18) . Though EqtII interacts with lipid membranes also in the absence of SM, our observations in GUVs clearly evidence a preference for the binding to SM-containing vesicles and highlight the role of SM as a receptor for EqtII. SM is a derivative of sphingosine, with a fatty acid attached to the 2-amino group through amide bonding. In mammals, this fatty acid usually has a long saturated acyl chain and together with the sphingosine acyl chain, forms the hydrophobic part of the sphingolipids (32). Such structure constitutes an excellent interaction partner for cholesterol, via both hydrogen bonding between the hydroxyl group of cholesterol and the amide group in the sphingosine, and hydrophobic interactions of the rigid cholesterol rings with the SM acyl chains (32) . As a consequence of this differential interaction, L o phases enriched in SM and cholesterol coexist with L d phases in model membranes containing phosphatidylcholine, cholesterol and SM over a large range of compositions, which include those mimicking the outer leaflet of the plasma membrane (26, 31, 34, 43, 44) . Indeed, a similar situation is believed to occur in the plasma membrane of mammalian cells, where the preferential interaction of sphingolipids with cholesterol gives rise to small domains of transient nature known as lipid rafts (32) . This notion is supported by experiments with dyes sensitive to lipid environment that support the existence of L o -like domains in the outer membrane of mammalian cells (45) (46) (47) .
In our experiments with phase segregated GUVs, EqtII bound preferentially to the L o phase. This phase distribution is probably due to the enrichment of SM in the L o phase, which acts as a specific receptor. But interestingly, a considerable amount of toxin concentrated at the phase boundaries. As shown by atomic force microscopy and crystallography studies, in model membranes the L o phase is thicker than the L d phase due to the higher conformational order of the acyl tails (33, (48) (49) (50) (51) (52) . To avoid the exposure of hydrophobic chains to the aqueous solvent, the lipids bend elastically at the domain interface, causing curvature stress, which has an energetic cost per length unit or line tension (26) . As a consequence, there is a higher concentration of packing defects at the phase boundaries, which likely favor binding of EqtII because of its amphipathic nature. A similar behavior has been observed for other proteins, like a peptide derived form helix 5 of Bax, PLA-2 and N-Ras (33, 53, 54) . This could be a mechanism to increase the local concentration of EqtII and hence to reach the threshold for pore formation (40) . Indeed, our experiments of membrane permeabilization in GUVs showed that at a certain toxin concentration, SM was not sufficient to promote pore opening, but phase coexistence was necessary. Interestingly, EqtII showed considerable permeabilizing activity in phase separated GUVs without SM. Addition of a small amount of SM to phase separated membranes, which would enhance EqtII binding, compensated to almost 100% permeabilization. Taken together, these observations highlight the dual role of SM on promoting EqtII activity. On one hand, it acts as a specific receptor for the toxin and promotes irreversible membrane binding (42, 55) . On the other hand, SM induces L d -L o phase separation in the presence of cholesterol (32) , thus collaborating in the creation of lipid interfaces that increase the local concentration of EqtII and enhance pore opening. Interestingly, a comparable situation occurs in the case of the cholesterol dependent cytolysins, an unrelated group of toxins that permeabilize membranes through formation of β-barrel pores. Likewise, cholesterol is implied both in the binding process, acting as a receptor, and in the mechanism of pore formation (56) . It is therefore tempting to hypothesize that SM and cholesterol dependent PFTs have evolved to use these features of the outer plasma membrane to optimize their activity. Concretely, they would do so by using lipids within lipid rafts as receptors and phase separation as a mechanism to increase local concentration. In fact, given the strong effect of phase separation on EqtII pore formation in model membranes, one may further speculate that its lytic activity in mammalian cells represents an indirect evidence of phase separation in membranes. 
